4//SEC Filing
LaChapelle Robin 4
Accession 0001104659-25-014170
CIK 0001868279other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 4:25 PM ET
Size
5.7 KB
Accession
0001104659-25-014170
Insider Transaction Report
Form 4
LaChapelle Robin
Chief Operating Officer
Transactions
- Award
Stock Option (right to buy)
2025-02-03+120,000→ 120,000 totalExercise: $27.56Exp: 2035-02-03→ Common Stock (120,000 underlying)
Footnotes (1)
- [F1]The shares underlying this option vest as to 25% on February 3, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through the applicable vesting date.
Documents
Issuer
ArriVent BioPharma, Inc.
CIK 0001868279
Entity typeother
Related Parties
1- filerCIK 0002009136
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 4:25 PM ET
- Size
- 5.7 KB